Source:Rivkees SA, Crawford JD. Dexamethasone treatment of virilizing congenital adrenal hyperplasia : the ability to achieve normal growth.
Pediatrics.
2000
;
106
:
767
–773.

Twenty-one children (17 boys) with 21ß-hydroxylase adrenal enzyme deficiency and 5 children (4 boys) with 11-hydroxylase enzyme deficiency were consecutively treated with dexamethasone instead of the more commonly used hydrocortisone and followed for an average of 7 years at 2 New England referral centers (Yale and Massachusetts General Hospital). Salt-losing patients were also treated with standard florinef doses. These 26 patients with congenital adrenal hyperplasia (CAH) were started on a daily morning dose of 0.25 to 0.28 mg/m2/day of dexamethasone administered as an elixir (0.1 mg/mL). The patients were evaluated every 3 to 4 months and the dose adjusted to maintain normal growth rate and normal adrenal androgen secretion for age. Most patients were maintained on a dose of 0.24 to 0.33...

You do not currently have access to this content.